---
title: "Sitagliptin - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db01261-mesh-d003924-1.html
toc: false 
---


Path ID: `DB01261_MESH_D003924_1`
{% include image.html url="images/db01261-mesh-d003924-1.png" file="db01261-mesh-d003924-1.png" alt="db01261-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000068900">MESH:D000068900 </a> | sitagliptin | Drug |
| <a href="https://identifiers.org/UniProt:P27487">UniProt:P27487 </a> | Dipeptidyl peptidase 4 | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-381771">reactome:R-HSA-381771 </a> | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | Pathway |
| <a href="https://identifiers.org/reactome:R-HSA-400511">reactome:R-HSA-400511 </a> | Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | Pathway |
| <a href="https://identifiers.org/GO:0030073">GO:0030073 </a> | Insulin Secretion | BiologicalProcess |
| <a href="https://identifiers.org/GO:0070091">GO:0070091 </a> | glucagon secretion | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D003924">MESH:D003924 </a> | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sitagliptin | NEGATIVELY REGULATES | Dipeptidyl Peptidase 4 |
| Dipeptidyl Peptidase 4 | PARTICIPATES IN | Synthesis, Secretion, And Inactivation Of Glucagon-Like Peptide-1 (Glp-1) |
| Dipeptidyl Peptidase 4 | PARTICIPATES IN | Synthesis, Secretion, And Inactivation Of Glucose-Dependent Insulinotropic Polypeptide (Gip) |
| Synthesis, Secretion, And Inactivation Of Glucagon-Like Peptide-1 (Glp-1) | NEGATIVELY CORRELATED WITH | Insulin Secretion |
| Synthesis, Secretion, And Inactivation Of Glucose-Dependent Insulinotropic Polypeptide (Gip) | NEGATIVELY CORRELATED WITH | Insulin Secretion |
| Synthesis, Secretion, And Inactivation Of Glucagon-Like Peptide-1 (Glp-1) | POSITIVELY CORRELATED WITH | Glucagon Secretion |
| Synthesis, Secretion, And Inactivation Of Glucose-Dependent Insulinotropic Polypeptide (Gip) | POSITIVELY CORRELATED WITH | Glucagon Secretion |
| Glucagon Secretion | POSITIVELY CORRELATED WITH | Diabetes Mellitus Type 2 |
| Insulin Secretion | NEGATIVELY CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01261#mechanism-of-action](https://go.drugbank.com/drugs/DB01261#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Sitagliptin](https://en.wikipedia.org/wiki/Sitagliptin)
  - [https://en.wikipedia.org/wiki/Dipeptidyl_peptidase-4_inhibitor](https://en.wikipedia.org/wiki/Dipeptidyl_peptidase-4_inhibitor)
  - [https://en.wikipedia.org/wiki/Incretin#Medical_uses](https://en.wikipedia.org/wiki/Incretin#Medical_uses)
  - [https://en.wikipedia.org/wiki/Type_2_diabetes#Pathophysiology](https://en.wikipedia.org/wiki/Type_2_diabetes#Pathophysiology)
